Printer Friendly

BIO-RAD ANNOUNCES SETTLEMENT OF EMINENT DOMAIN ACTION

 BIO-RAD ANNOUNCES SETTLEMENT OF EMINENT DOMAIN ACTION
 HERCULES, Calif., July 1 /PRNewswire/ -- Bio-Rad Laboratories Inc.


(AMEX: BIO.A) announced today that it has reached a settlement with the California Department of Transportation (CALTRANS) in connection with CALTRANS' eminent domain action which took a portion of the company's facilities in Richmond, Calif. Both parties agreed to the settlement prior to a trial which would have been the culmination of litigation which began in 1985 when Bio-Rad contested the amount offered in compensation for its facilities. In February 1991, the California Superior Court upheld certain legal grounds for Bio-Rad's claims for additional compensation.
 The amount of the settlement is $23.5 million, which includes interest on the amount of agreed damages. The settlement will result in an after-tax gain of approximately $12 million which will be reported as Other Income by Bio-Rad in the second quarter of 1992. These amounts are in addition to the $6.7 million paid to Bio-Rad by CALTRANS in 1984.
 Bio-Rad's President, David Schwartz, stated, "The proceeds will provide Bio-Rad with partial compensation for funds previously expended as a result of the 1984 condemnation. While the settlement is not entirely satisfactory to Bio-Rad, it will avoid further costly litigation for both sides in this protracted dispute. Replenishment of these funds will permit the company to consider restructuring actions to return Bio-Rad to its former level of profitability."
 Bio-Rad Laboratories is a multinational manufacturer and distributor of life science research products, clinical diagnostics, and analytical instruments based in Hercules.
 -0- 7/1/92
 /CONTACT James L. Viglienzone of Bio-Rad, 510-724-7000/
 (BIO.A) CO: Bio-Rad Laboratories Inc. ST: California IN: MTC SU:


MM-MC -- SF001 -- 5477 07/01/92 08:03 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 1, 1992
Words:282
Previous Article:SHOP 'N SAVE SUPPORTS '5 A DAY' CAMPAIGN
Next Article:SOUTHERN NATIONAL INCREASES DIVIDEND FOR 20TH STRAIGHT YEAR
Topics:


Related Articles
BIO-RAD LABORATORIES ANNOUNCES SALE OF OPHTHALMIC DIVISION
BIO-RAD ANNOUNCES SECOND QUARTER SALES AND EARNINGS
BIO-RAD ANNOUNCES SETTLEMENT OF GOVERNMENT CIVIL PROCEEDING
BIO-RAD ANNOUNCES RECEIPT OF $2 MILLION GRANT
BIO-RAD REPORTS RECORD RESULTS FOR THE FIRST QUARTER 1996 AND ANNOUNCES STOCK SPLIT
Bio-RAD wins patent suit for HIV-2 test against Genelabs.
Bio-Rad and Immucor Announce French Distribution Agreement.
Bio-Rad and Immucor Announce French Distribution Agreement.
Bio-Rad Files 13D With SEC.
BioSource rebuffs Bio-Rad's unsolicited offer.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters